GGrantIndex
Sort

82,697 grants matching vaccine development

Project 2: PanbetaCoV protein vaccine design

$2,828,814
Kevin Wiehe · Duke University · P01 · FY2023 · AI

Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication

$2,826,477
Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2022 · AI

Novel SIVsmm strains for analysis of mucosal transmission and vaccine protection

$2,826,440
George M Shaw · University Of Pennsylvania · P01 · FY2013 · AI

Role of antigen-specific T cell responses in the control of TB

$2,826,310
Henry M Blumberg · Emory University · U19 · FY2020 · AI

Integrated Support Services-Animal

$2,825,439
John R. Murphy · Boston University Medical Campus · UC7 · FY2015 · AI

Mechanisms of naturally-acquired immunity to malaria and clinical trials of anti-malaria monoclonal antibodies

$2,825,052
Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Structure-function analysis of infection- and vaccine-induced B-cell repertoires

$2,824,178
Stephen C Harrison · Boston Children'S Hospital · P01 · FY2015 · AI

Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)

$2,823,243
Casey Koontz · · N01 · FY2015 · AI

CTSA INFRASTRUCTURE FOR AIDS RESEARCH

$2,823,010
Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2010 · RR

CTSA INFRASTRUCTURE FOR AIDS RESEARCH

$2,823,009
Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2010 · RR

Bone Marrow Transplantation in Human Disease

$2,820,874
Richard J Jones · Johns Hopkins University · P01 · FY2011 · CA

Autonomously deploying, co-evolving SARS-CoV-2 antiviral: a new paradigm for pandemic prevention

$2,820,494
Robert Rodick · Vxbiosciences, Inc. · R01 · FY2021 · AI

Design and evaluation of pan-CoV vaccines

$2,819,456
Yoshihiro Kawaoka · University Of Wisconsin-Madison · P01 · FY2023 · AI

Epigenomic analysis of primary immune cells from young and old animals

$2,819,339
Myong-Hee Sung · National Institute On Aging · ZIA · FY2024 · AG

Advancing Transplantation Outcomes in Children

$2,818,988
David Michael Briscoe · Boston Children'S Hospital · U01 · FY2025 · AI

HIV Database and Analysis Unit

$2,818,637
National Institute Of Allergy And Infectious Diseases · Y01 · FY2025 · AI

Molecular and Immunologic Analysis of the Pathobiology of Anthrax

$2,818,251
Oklahoma Medical Research Foundation · U19 · FY2005 · AI

The UPMC Sexually Transmitted Infections Cooperative Research Center

$2,818,044
Toni Darville · University Of Pittsburgh At Pittsburgh · U19 · FY2012 · AI

Gene-Environment Interactions in an Autism Birth Cohort

$2,817,872
W. Ian Lipkin · Columbia University Health Sciences · U01 · FY2007 · NS

Core F – High-Throughput Screening

$2,817,180
Robert Marsden Cox · Emory University · U19 · FY2022 · AI

Systems Genetics of Tuberculosis

$2,817,044
Christopher M Sassetti · Univ Of Massachusetts Med Sch Worcester · P01 · FY2024 · AI

Epitope-targeted Vaccines for HIV-1 Prevention

$2,816,030
Xiangpeng Kong · New York University School Of Medicine · P01 · FY2015 · AI

Influenza Immunity: Protective Mechanisms Against Pandemic Respiratory Virus

$2,815,441
Mark M Davis · Stanford University · U19 · FY2012 · AI

SPORE in Prostate Cancer

$2,815,158
Sloan-Kettering Institute For Cancer Res · P50 · FY2002 · CA

Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases

$2,815,090
Corey Casper · Access To Advanced Health Institute · N01 · FY2024 · AI